What does HTS CLINIC do?

HTS CLINIC is a specialist medical practice in Etterbeek. Private Limited, started on 16 March 2022, 1 establishment.

What is the address of HTS CLINIC?

The registered office of HTS CLINIC is located at Tervurenlaan 36 box 5, 1040 Etterbeek.

Is HTS CLINIC still active?

Yes. According to the CBE (31 October 2026) HTS CLINIC is active, legal situation “Normale toestand”, started on 16 March 2022.

Is HTS CLINIC registered on Peppol?

Yes, HTS CLINIC is registered on the Peppol network with ID 0208:0783482856.

What is the enterprise number of HTS CLINIC?

The enterprise number of HTS CLINIC is BE0783482856.

When was HTS CLINIC founded?

HTS CLINIC was founded on 16 March 2022.

Who are the directors of HTS CLINIC?

According to the 2025 annual accounts, the directors of HTS CLINIC are: Jean DEVROYE.

Is HTS CLINIC a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 March 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did HTS CLINIC make in 2025?

HTS CLINIC posted a profit after taxes of € 168,864 in financial year 2025.

What is the revenue of HTS CLINIC?

As a small company, HTS CLINIC is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 270,907.

How much does an employee at HTS CLINIC earn?

The average wage cost per full-time employee at HTS CLINIC was € 59,900 in 2024: staff costs of € 203,771 for 3.4 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does HTS CLINIC have?

According to the 2025 annual accounts, HTS CLINIC has 0.7 full-time equivalents (FTE).

HTS CLINIC (Private Limited) - Etterbeek - BE0783482856

Dossier HTS CLINIC, printed on 1 November 2026 from databakkes.be/en/0783482856/hts-clinic. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Shrinking team NBB

FTE fell two years in a row, from 10.8 to 0.7.
Busy address KBO

11 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

HTS CLINIC from Etterbeek, company number BE0783482856, closed financial year 2025 with a result of € 168,864 after tax. For that financial year HTS CLINIC recorded a gross margin of € 270,907 and equity of € 170,364. Compared with financial year 2024, the result moved from € 162,599 to € 168,864. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2026.

What it is worth Growing

€ 170,364

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 168,864

▲ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 71,797

▼ 14% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 155,519 paid out

92 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

0.7

▼ 2.7 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 21,486

▼ 89% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,891

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 24,847

▲ € 23,025 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 67,836

▼ 16% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 413,794 Gross margin 2022: € 413,794 First fiscal year in the series	€ 590,437 Gross margin 2023: € 590,437 ▲ 43% vs 2022 (€ 413,794) Favourable step	€ 477,569 Gross margin 2024: € 477,569 ▼ 19% vs 2023 (€ 590,437) Unfavourable step	€ 270,907 Gross margin 2025: € 270,907 ▼ 43% vs 2024 (€ 477,569) Unfavourable step	▼ 43%
Profit after taxes	€ 22,963 Profit after taxes 2022: € 22,963 First fiscal year in the series	€ -20,043 Profit after taxes 2023: € -20,043 ▼ € 43,005 vs 2022 (€ 22,963) Unfavourable step	€ 162,599 Profit after taxes 2024: € 162,599 ▲ € 182,642 vs 2023 (€ -20,043) Favourable step	€ 168,864 Profit after taxes 2025: € 168,864 ▲ 4% vs 2024 (€ 162,599) Favourable step	▲ 4%
Equity	€ 14,463 Equity 2022: € 14,463 First fiscal year in the series	€ -5,580 Equity 2023: € -5,580 ▼ € 20,043 vs 2022 (€ 14,463) Unfavourable step	€ 157,019 Equity 2024: € 157,019 ▲ € 162,599 vs 2023 (€ -5,580) Favourable step	€ 170,364 Equity 2025: € 170,364 ▲ 8% vs 2024 (€ 157,019) Favourable step	▲ 8%
Total debts	€ 537,429 Total debts 2022: € 537,429 First fiscal year in the series	€ 603,455 Total debts 2023: € 603,455 ▲ 12% vs 2022 (€ 537,429) Unfavourable step	€ 124,070 Total debts 2024: € 124,070 ▼ 79% vs 2023 (€ 603,455) Favourable step	€ 93,683 Total debts 2025: € 93,683 ▼ 24% vs 2024 (€ 124,070) Favourable step	▼ 24%
Cash	€ 85,899 Cash 2022: € 85,899 First fiscal year in the series	€ 130,238 Cash 2023: € 130,238 ▲ 52% vs 2022 (€ 85,899) Favourable step	€ 83,928 Cash 2024: € 83,928 ▼ 36% vs 2023 (€ 130,238) Unfavourable step	€ 71,797 Cash 2025: € 71,797 ▼ 14% vs 2024 (€ 83,928) Unfavourable step	▼ 14%
Retained profit	€ 12,963 Retained profit 2022: € 12,963 First fiscal year in the series	€ -7,080 Retained profit 2023: € -7,080 ▼ € 20,043 vs 2022 (€ 12,963) Unfavourable step	€ 155,519 Retained profit 2024: € 155,519 ▲ € 162,599 vs 2023 (€ -7,080) Favourable step	€ 168,864 Retained profit 2025: € 168,864 ▲ 9% vs 2024 (€ 155,519) Favourable step	▲ 9%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 155,519 Dividend 2025: € 155,519 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 113,789 Bank debt 2023: € 113,789 Unchanged (€ 0) Unfavourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 113,789) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 551,891 Balance sheet total 2022: € 551,891 First fiscal year in the series	€ 597,875 Balance sheet total 2023: € 597,875 ▲ 8% vs 2022 (€ 551,891) Unchanged	€ 281,089 Balance sheet total 2024: € 281,089 ▼ 53% vs 2023 (€ 597,875) Unchanged	€ 264,047 Balance sheet total 2025: € 264,047 ▼ 6% vs 2024 (€ 281,089) Unchanged	▼ 6%
Employees (FTE)	10.4 Employees (FTE) 2022: 10.4 First fiscal year in the series	10.8 Employees (FTE) 2023: 10.8 ▲ 0.4 vs 2022 (10.4) Unchanged	3.4 Employees (FTE) 2024: 3.4 ▼ 7.4 vs 2023 (10.8) Unchanged	0.7 Employees (FTE) 2025: 0.7 ▼ 2.7 vs 2024 (3.4) Unchanged	▼ 2.7

Key figures of HTS CLINIC, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to HTS CLINIC?

What happened at HTS CLINIC in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 15, 2026 New annual accounts for financial year 2025: profit of € 168,864 (▲ 4% vs 2024). Source: NBB ↗
Mar 16, 2022 New establishment in Etterbeek. KBO
2022 Jean DEVROYE became a director. NBB
Mar 16, 2022 Start of the company according to the CBE. KBO

In short

From € 22,963 profit in 2022 to € 168,864 profit in 2025.

Paid € 121,522 in corporate taxes since 2022.

Best year ever: 2025, with € 168,864 profit.

On average € 140,500 of value added per employee in 2024.

Original PDFs at the National Bank ↗

Management

Jean DEVROYE

HTS CLINIC

Devroye Instruments

Behind HTS CLINIC is Jean DEVROYE. Jean DEVROYE is also behind Devroye Instruments.

Directors

According to the 2025 annual accounts

Jean DEVROYE

Director

Also active at: Devroye Instruments

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Tervurenlaan 36 box 5

1040 Etterbeek

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 11 companies are registered at this address.

All companies at this address →

Wakuti Belgium

G.A.S. FUND

ASSOCIATION EUROPEENNE DES PROFESSIONS IMMOBILIERES

BONFINA EUROPE

€ 316,164 revenue · 2025

VM EUROPE

€ 6.3 million revenue · 2025

+6 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0783.482.856
VAT number: BE 0783.482.856
Registered office: Tervurenlaan 36 bus 5, 1040 Etterbeek
Names & denominations: HTS CLINIC
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 16 March 2022
Peppol: Active · Active since 11 Feb 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗